首页> 美国卫生研究院文献>Translational Medicine @ UniSa >Combined Administration of Oxycodone/Naloxone in Chronic Osteo-Articular Diseases Pain Therapy
【2h】

Combined Administration of Oxycodone/Naloxone in Chronic Osteo-Articular Diseases Pain Therapy

机译:羟考酮/纳洛酮在慢性骨-关节疾病疼痛治疗中的联合给药

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study is the analysis of the beneficial impact of using opioid receptor antagonist associated to opioid analgesic on the quality of life in patients suffering from chronic non-cancer pain.We recruited 60 patients suffering from osteo-articular diseases who were randomized into two groups of treatment. The group A was treated with the association of opioid receptor antagonist and opioid agonist, represented by Oxycodone. The group B was treated with the opioid analgesics Oxycodone, transdermal Fentanil, and Hidromorphone, without the opioid antagonist. The end-points assessed were the duration of titration, the average reached dosage, the duration of the stability of dosage and the opioid–induced constipation (OIC) using the BFI.
机译:这项研究的目的是分析使用与阿片类镇痛药相关的阿片类受体拮抗剂对慢性非癌性疼痛患者的生活质量的有益影响。我们招募了60名患有骨关节疾病的患者,随机分为两组治疗。 A组接受了以羟考酮为代表的阿片受体拮抗剂和阿片激动剂的联合治疗。 B组用阿片类镇痛药羟考酮,透皮芬太尼和盐酸吗啡酮治疗,无阿片类拮抗剂。评估的终点是滴定的持续时间,平均达到的剂量,剂量稳定的持续时间以及使用BFI的阿片类药物引起的便秘(OIC)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号